Under EU law, active pharmaceutical ingredients (APIs) shipped from India and other non-listed countries must be supported by a written confirmation certificate stating the product meets good ...

About MMJ International Holdings MMJ International Holdings is a leading biopharmaceutical company focused on the development of plant-derived, FDA-approved cannabinoid medicines. By prioritizing the ...

Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP March 31, 2026 11:00 AM EDTCompany ...

"The CMS pilot program could establish a federally supported cannabinoid treatment category before FDA botanical drug ...

SHANDONG, SHANDONG, CHINA, April 1, 2026 / EINPresswire.com / — Beyond the Bottle: How Jasmine, a Top 10 Glass Wine Bottles ...

FDA provided constructivefeedback on Company’s analytical similarity strategy under the 351(k) biosimilar pathway ...

In line with the drug manufacturing practices followed in regulated geographies, Central Drug Standards Control Organization (CDSCO) has successfully concluded training sessions for drug inspectors on ...

Regulatory pressure from GxP, 21 CFR Part 11, and AI/ML guidance elevates requirements for audit trails, data lineage, ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, March 24, 2026 /EINPresswire.com/ -- The global cohesive bandage market has ...

Evolve Science launches a transparent, U.S.-based peptide and longevity platform sourcing exclusively from FDA-registered ...

The Drugs Technical Advisory Board (DTAB), which recommends on policy decisions related to technical matters on the Drugs and Cosmetics Act and relevant rules, has given its green signal to amend the ...

BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced ...